Activation of the transcriptional function of the NF-kB protein c-Rel by O-GlcNAc glycosylation

Science Signaling

Volumn 6, Issue 290, 2013, Pages

  Ramakrishnan, Parameswaran ^a,d   Clark, Peter M ^b   Mason, Daniel E ^c   Peters, Eric C ^c   Hsieh Wilson, Linda C ^b   Baltimore, David ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b California Institute of Technology   (United States)

^c GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; N ACETYLGLUCOSAMINE; O LINKED BETA N ACETYLGLUCOSAMINE; SERINE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR REL; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; GLYCOSYLATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; TRANSACTIVATION; TRANSCRIPTION INITIATION;

ACETYLGLUCOSAMINE; ACYLATION; ANIMALS; BINDING SITES; BLOTTING, WESTERN; CELL LINE, TUMOR; CELLS, CULTURED; GLYCOSYLATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEK293 CELLS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; JURKAT CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; NF-KAPPA B; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-REL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SERINE; SIGNAL TRANSDUCTION;

EID: 84884139186     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2004097     Document Type: Article

References (57)

1. D. Baltimore, NF-KB is 25. Nat. Immunol. 12, 683-685 (2011).
2. M. S. Hayden, S. Ghosh, NF-KB in immunobiology. Cell Res. 21, 223-244 (2011).
3. N. D. Perkins, Post-Translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25, 6717-6730 (2006).
4. J. Leidner, L. Palkowitsch, U. Marienfeld, D. Fischer, R. Marienfeld, Identification of lysine residues critical for the transcriptional activity and polyubiquitination of the NF-KB family member RelB. Biochem. J. 416, 117-127 (2008).
5. G. W. Hart, M. P. Housley, C. Slawson, Cycling of O-Linked b-N-Acetylglucosamine on nucleocytoplasmic proteins. Nature 446, 1017-1022 (2007).
6. G. W. Hart, C. Slawson, G. Ramirez-Correa, O. Lagerlof, Cross talk between O-GlcNAcylation and phosphorylation: Roles in signaling, transcription, and chronic disease. Ann. Rev. Biochem. 80, 825-858 (2011).
7. J. E.Rexach,P.M. Clark, D. E. Mason, R. L. Neve, E. C. Peters, L. C. Hsieh-Wilson, Dynamic O-GlcNAc modification regulates CREB-Mediated gene expression and memory formation. Nat. Chem. Biol. 8, 253-261 (2012).
8. C. Slawson, N. E. Zachara, K. Vosseller, W. D. Cheung, M. D. Lane, G. W. Hart, Perturbations in O-Linked b-N-Acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. J. Biol. Chem. 280, 32944-32956 (2005).
9. Z.Wang, N. D. Udeshi, C. Slawson, P. D. Compton, K. Sakabe,W. D. Cheung, J. Shabanowitz, D. F. Hunt, G. W. Hart, Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Sci. Signal. 3, ra2 (2010).
10. W. H. Yang, J. E. Kim, H. W. Nam, J. W. Ju, H. S. Kim, Y. S. Kim, J. W. Cho, Modification of p53 with O-Linked N-Acetylglucosamine regulates p53 activity and stability. Nat. Cell Biol. 8, 1074-1083 (2006).
11. J. C. Chatham, R. B. Marchase, Protein O-GlcNAcylation: A critical regulator of the cellular response to stress. Curr. Signal Transduct. Ther. 5, 49-59 (2010).
12. J. A. Hanover, M. W. Krause, D. C. Love, Bittersweet memories: Linking metabolism to epigenetics through O-GlcNAcylation. Nat. Rev. Mol. Cell Biol. 13, 312-321 (2012).
13. R. Shafi, S. P. Iyer, L. G. Ellies, N. O?Donnell, K.W. Marek, D. Chui, G.W. Hart, J. D. Marth, The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc. Natl. Acad. Sci. U.S.A. 97, 5735-5739 (2000).
14. N. O?Donnell, N. E. Zachara, G. W. Hart, J. D. Marth, Ogt-Dependent X-Chromosomelinked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol. Cell. Biol. 24, 1680-1690 (2004).
15. L. R. James, D. Tang, A. Ingram, H. Ly, K. Thai, L. Cai, J. W. Scholey, Flux through the hexosamine pathway is a determinant of nuclear factor kB-Dependent promoter activation. Diabetes 51, 1146-1156 (2002).
16. K. K. Yerneni, W. Bai, B. V. Khan, R. M. Medford, R. Natarajan, Hyperglycemia-Induced activation of nuclear transcription factor kB in vascular smooth muscle cells. Diabetes 48, 855-864 (1999).
17. M. Yuan, N. Konstantopoulos, J. Lee, L. Hansen, Z. W. Li, M. Karin, S. E. Shoelson, Reversal of obesity-And diet-Induced insulin resistance with salicylates or targeted disruption of Ikkb. Science 293, 1673-1677 (2001).
18. S. E. Lamhamedi-Cherradi, S. Zheng, B. A. Hilliard, L. Xu, J. Sun, S. Alsheadat, H. C. Liou, Y. H. Chen, Transcriptional regulation of type I diabetes by NF-KB. J. Immunol. 171, 4886-4892 (2003).
19. Y. Zhao, B. Krishnamurthy, Z. U. Mollah, T. W. Kay, H. E. Thomas, NF-KB in type 1 diabetes. Inflamm. Allergy Drug Targets 10, 208-217 (2011).
20. A. Golks, T. T. Tran, J. F. Goetschy, D. Guerini, Requirement for O-Linked N-Acetylglucosaminyltransferase in lymphocytes activation. EMBO J. 26, 4368-4379 (2007).
21. W. H. Yang, S. Y. Park, H.W. Nam, H. Kimdo, J. G. Kang, E. S. Kang, Y. S. Kim, H. C. Lee, K. S. Kim, J. W. Cho, NFkB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proc. Natl. Acad. Sci. U.S.A. 105, 17345-17350 (2008).
22. D. F. Allison, J. J. Wamsley, M. Kumar, D. Li, L. G. Gray, G. W. Hart, D. R. Jones, M. W. Mayo, Modification of RelA by O-Linked N-Acetylglucosamine links glucose metabolism to NF-KB acetylation and transcription. Proc. Natl. Acad. Sci. U.S.A. 109, 16888-16893 (2012).
23. P. Ramakrishnan, D. A. Kahn, D. Baltimore, Anti-Apoptotic effect of hyperglycemia can allow survival of potentially autoreactive T cells. Cell Death Differ. 18, 690-699 (2011).
24. R. S. Haltiwanger, K. Grove, G. A. Philipsberg, Modulation of O-Linked N-Acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-B-Nacetylglucosaminidase inhibitor O-(2-Acetamido-2-Deoxy-D- Glucopyranosylidene)amino-N-Phenylcarbamate. J. Biol. Chem. 273, 3611-3617 (1998).
25. J. E. Rexach, C. J. Rogers, S. H. Yu, J. Tao, Y. E. Sun, L. C. Hsieh-Wilson, Quantification of O-Glycosylation stoichiometry and dynamics using resolvable mass tags. Nat. Chem. Biol. 6, 645-651 (2010).
26. T. D. Gilmore, S. Gerondakis, The c-Rel transcription factor in development and disease. Genes Cancer 2, 695-711 (2011).
27. C. Slawson, G. W. Hart, O-GlcNAc signalling: Implications for cancer cell biology. Nat. Rev. Cancer 11, 678-684 (2011).
28. C. Abbadie, N. Kabrun, F. Bouali, J. Smardova, D. Stéhelin, B. Vandenbunder, P. J. Enrietto, High levels of c-Rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell 75, 899-912 (1993).
29. S. Gerondakis, R. Grumont, R. Gugasyan, L. Wong, I. Isomura, W. Ho, A. Banerjee, Unravelling the complexities of the NF-KB signalling pathway using mouse knockout and transgenic models. Oncogene 25, 6781-6799 (2006).
30. L. Venkataraman, S. J. Burakoff, R. Sen, FK506 inhibits antigen receptor-Mediated induction of c-Rel in B and T lymphoid cells. J. Exp. Med. 181, 1091-1099 (1995).
31. J. C. Nolz, M. E. Fernandez-Zapico, D. D. Billadeau, TCR/CD28-Stimulated actin dynamics are required for NFAT1-Mediated transcription of c-Rel leading to CD28 response element activation. J. Immunol. 179, 1104-1112 (2007).
32. R.G. Bryan, Y. Li, J. H. Lai, M. Van, N. R. Rice, R. R. Rich, T. H. Tan, Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells. Mol. Cell. Biol. 14, 7933-7942 (1994).
33. V. S. Shapiro, K. E. Truitt, J. B. Imboden, A. Weiss, CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol. Cell. Biol. 17, 4051-4058 (1997).
34. M. P. Housley, J. T. Rodgers, N. D. Udeshi, T. J. Kelly, J. Shabanowitz, D. F. Hunt, P. Puigserver, G. W. Hart, O-GlcNAc regulates FoxO activation in response to glucose. J. Biol. Chem. 283, 16283-16292 (2008).
35. K. Bunting, J. Wang, M. F. Shannon, Control of interleukin-2 gene transcription: A paradigm for inducible, tissue-Specific gene expression. Vitam. Horm. 74, 105-145 (2006).
36. S. M. Kang, A. C. Tran, M. Grilli, M. J. Lenardo, NF-Kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science 256, 1452-1456 (1992).
37. K. C. Herold, Achieving antigen-Specific immune regulation. J. Clin. Invest. 113, 346-349 (2004).
38. F. Köntgen, R. J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, S. Gerondakis, Mice lacking the c-Rel proto-Oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9, 1965-1977 (1995).
39. B. A. Hilliard, N. Mason, L. Xu, J. Sun, S. E. Lamhamedi-Cherradi, H. C. Liou, C. Hunter, Y. H. Chen, Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J. Clin. Invest. 110, 843-850 (2002).
40. K. Bunting, S. Rao, K. Hardy, D. Woltring, G. S. Denyer, J. Wang, S. Gerondakis, M. F. Shannon, Genome-wide analysis of gene expression in T cells to identify targets of the NF-KB transcription factor c-Rel. J. Immunol. 178, 7097-7109 (2007).
41. M. D. Roos, W. Xie, K. Su, J. A. Clark, X. Yang, E. Chin, A. J. Paterson, J. E. Kudlow, Streptozotocin, an analog of N-Acetylglucosamine, blocks the removal of O-GlcNAc from intracellular proteins. Proc. Assoc. Am. Physicians 110, 422-432 (1998).
42. A. G. Martin, B. San-Antonio, M. Fresno, Regulation of nuclear factor kB transactivation. Implication of phosphatidylinositol 3-Kinase and protein kinase C z in c-Rel activation by tumor necrosis factor a. J. Biol. Chem. 276, 15840-15849 (2001).
43. H. C. Liou, C. Y. Hsia, Distinctions between c-Rel and other NF-KB proteins in immunity and disease. Bioessays 25, 767-780 (2003).
44. D. B. Huang, Y. Q. Chen, M. Ruetsche, C. B. Phelps, G. Ghosh, X-Ray crystal structure of proto-Oncogene product c-Rel bound to the CD28 response element of IL-2. Structure 9, 669-678 (2001).
45. L. P. Kane, J. Lin, A. Weiss, It's all Rel-Ative: NF-KB and CD28 costimulation of T-Cell activation. Trends Immunol. 23, 413-420 (2002).
46. T. S. Doi, T. Takahashi, O. Taguchi, T. Azuma, Y. Obata, NF-KB RelA-Deficient lymphocytes: Normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185, 953-961 (1997).
47. D. Xing, K. Gong, W. Feng, S. E. Nozell, Y. F. Chen, J. C. Chatham, S. Oparil, O-GlcNAc modification of NFkB p65 inhibits TNF-A-Induced inflammatory mediator expression in rat aortic smooth muscle cells. PLoS One 6, e24021 (2011).
48. C. W. Müller, S. C. Harrison, The structure of the NF-KB p50:DNA-Complex: A starting point for analyzing the Rel family. FEBS Lett. 369, 113-117 (1995).
49. Y. Gao, J. Miyazaki, G. W. Hart, The transcription factor PDX-1 is post-Translationally modified by O-Linked N-Acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 b-Cells.Arch. Biochem. Biophys. 415, 155-163 (2003).
50. M. Hiromura, C. H. Choi, N. A. Sabourin, H. Jones, D. Bachvarov, A. Usheva, YY1 is regulated by O-Linked N-Acetylglucosaminylation (O-GlcNAcylation). J. Biol. Chem. 278, 14046-14052 (2003).
51. C. K. Ea, D. Baltimore, Regulation of NF-KB activity through lysine monomethylation of p65. Proc. Natl. Acad. Sci. U.S.A. 106, 18972-18977 (2009).
52. L. F. Chen, Y. Mu, W. C. Greene, Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-KB. EMBO J. 21, 6539-6548 (2002).
53. I. Isomura, S. Palmer, R. J. Grumont, K. Bunting, G. Hoyne, N. Wilkinson, A. Banerjee, A. Proietto, R. Gugasyan, L. Wu, A. McNally, R. J. Steptoe, R. Thomas, M. F. Shannon, S. Gerondakis, c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J. Exp. Med. 206, 3001-3014 (2009).
54. P. Ramakrishnan, D. Baltimore, Sam68 is required for both NF-KB activation and apoptosis signaling by the TNF receptor. Mol. Cell 43, 167-179 (2011).
55. L. Wells, K. Vosseller, R. N. Cole, J. M. Cronshaw, M. J. Matunis, G. W. Hart, Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-Translational modifications. Mol. Cell. Proteomics 1, 791-804 (2002).
56. R. M. O?Connell, A. B. Balazs, D. S. Rao, C. Kivork, L. Yang, D. Baltimore, Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations. PLoS One 5, e12009 (2010).
57. E. Schreiber, P. Matthias, M. M. Müller, W. Schaffner, Rapid detection of octamer binding proteins with "mini-Extracts," prepared from a small number of cells. Nucleic Acids Res. 17, 6419 (1989).